Ubs Group Ag Ab Cellera Biologics Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Ubs Group Ag holds 21,745 shares of ABCL stock, worth $63,495. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,745

Previous 94,991 77.11%

Holding current value

$63,495

Previous $281,000 80.07%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.39 - $3.49 $175,057 - $255,628	-73,246 Reduced 77.11%	21,745 $56,000
Q2 2024 Aug 13, 2024	SELL	$2.73 - $4.73 $19,066 - $33,034	-6,984 Reduced 6.85%	94,991 $281,000
Q1 2024 May 13, 2024	BUY	$4.29 - $5.97 $426,747 - $593,865	99,475 Added 3979.0%	101,975 $461,000
Q4 2023 Feb 09, 2024	BUY	$3.91 - $5.93 $9,775 - $14,825	2,500 New	2,500 $14,000
Q2 2023 Aug 11, 2023	SELL	$5.66 - $7.59 $302,991 - $406,307	-53,532 Reduced 80.02%	13,366 $86,000
Q1 2023 May 12, 2023	BUY	$7.31 - $11.18 $165,586 - $253,249	22,652 Added 51.2%	66,898 $504,000
Q4 2022 Feb 08, 2023	SELL	$9.48 - $14.52 $479,612 - $734,595	-50,592 Reduced 53.35%	44,246 $448,000
Q3 2022 Nov 10, 2022	BUY	$9.2 - $13.68 $492,043 - $731,647	53,483 Added 129.33%	94,838 $938,000
Q2 2022 Aug 10, 2022	SELL	$5.72 - $10.65 $120,520 - $224,395	-21,070 Reduced 33.75%	41,355 $440,000
Q1 2022 May 16, 2022	SELL	$7.46 - $14.14 $125,074 - $237,071	-16,766 Reduced 21.17%	62,425 $609,000
Q4 2021 Feb 14, 2022	BUY	$12.99 - $17.73 $205,034 - $279,850	15,784 Added 24.89%	79,191 $1.13 Million
Q3 2021 Nov 15, 2021	BUY	$14.85 - $21.34 $332,476 - $477,781	22,389 Added 54.58%	63,407 $1.27 Million
Q2 2021 Aug 13, 2021	BUY	$20.19 - $34.17 $766,190 - $1.3 Million	37,949 Added 1236.53%	41,018 $902,000
Q1 2021 May 12, 2021	BUY	$23.29 - $53.2 $71,290 - $162,845	3,061 Added 38262.5%	3,069 $104,000
Q4 2020 Feb 11, 2021	BUY	$39.0 - $58.9 $312 - $471	8 New	8 $0

Others Institutions Holding ABCL

# of Institutions

154

Shares Held

109M

Call Options Held

153K

Put Options Held

194K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $833M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account